Recent Updates
Recently added Catalysts

non-cathartic CTC

Phase 2

Colonic Polyps | Unknown | Other |GE HealthCare Technologies Inc.|Last Updated: Aug 5, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
ACTIVE_CONTROLLED
Total Trials1
Total Enrollment605
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01200303Evaluation of Computer-assisted, Non-cathartic CT ColonographyPHASE2 COMPLETED 605Jun 1, 2005Jan 1, 2011Aug 5, 20153 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Performance for detection of adenomatous colonic polyps > 6mm
on per subject basis, metric will be assessed at unblinding OC (w/i 5 weeks enrollment); for cohort, summary statistics will be generated at study completion

this is a prospective test comparison of non-cathartic, CAD-assisted CT Colonography to segmentally unblinded optical colonoscopy (OC), latter serving with pathology specimens as reference standard for presence of polyps.

Secondary Endpoints
Patient comfort associated with non-cathartic exam preparation
on per subject basis, outcome will be assessed at 5 weeks post enrollment (following OC); for cohort, summary statistics will be generated at study completion
Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeDIAGNOSTIC
Treatment Arms
ArmTypeDescription
non-cathartic CTC and OCACTIVE_COMPARATORThis is a single arm, open label, prospective test comparison of non-cathartic, CAD-assisted CTC to segmentally unblinded optical colonoscopy (OC). All study subjects receive both tests, starting with CTC, followed by OC within 5 weeks. CTC results are recorded and revealed to endoscopist on a segment-by-segment basis after initial (blinded) OC evaluation; endoscopist can double check / confirm lesion presence after unblinding and this second read serves as reference standard.
Interventions
NameTypeDescription
non-cathartic CTCPROCEDUREnon-cathartic, CAD-assisted CT Colonography
Unlock Study Design Details
Eligibility Criteria
Age Range50 Years — 80 Years
SexALL
Healthy VolunteersYes
Study Sites3

Inclusion Criteria: * age 50-80, eligible for colon screening Exclusion Criteria: * prior anatomic colon screening exam (optical colonoscopy, sigmoidoscopy, barium enema, CT Colonography) within last 5 years * personal history of inflammatory bowel disease, polyposis syndrome, colo-rectal cancer,...

Countries:United States
Unlock Eligibility Criteria